<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02789449</url>
  </required_header>
  <id_info>
    <org_study_id>27-203 ex 14-15</org_study_id>
    <nct_id>NCT02789449</nct_id>
  </id_info>
  <brief_title>Estimation of Pulmonary Capillary Blood Volume in Pre- and Postcapillary Pulmonary Hypertension</brief_title>
  <official_title>Non-invasive Estimation of Pulmonary Capillary Blood Volume in Pre- and Postcapillary Pulmonary Hypertension - a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate the role of the non-invasive assessment of nitric
      oxyde (NO) diffusion capacity (DLNO) in the differential diagnosis of different forms of
      pulmonary hypertension (PH). DLNO alone and in combination with the measurement of carbon
      monoxide (CO) diffusion capacity (DLCO) may help to differentiate between pre- and
      postcapillary forms of pulmonary hypertension. This hypothesis is based on the fact that NO
      has a much higher affinity to hemoglobin as compared to CO and may therefore its decrease may
      more specifically identify the limiting factors between the alveolar space and the lung
      capillaries including left heart failure (cardiac edema).

      As there are no available published data yet to answer this question investigators aim to
      perform a small pilot study. The results of this study may allow the planning of a
      prospective study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in DLNO (in mmol/min/kPa) between the two predefined groups (patients with clear precapillary PH (PAWP&lt;12mmHg) vs. clear postcapillary PH (PAWP&gt;18mmHg))</measure>
    <time_frame>one hour</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">17</enrollment>
  <condition>Hypertension Pulmonary</condition>
  <arm_group>
    <arm_group_label>precapillary</arm_group_label>
    <description>patients with PH and PAWP&lt;12mmHg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>postcapillary</arm_group_label>
    <description>patients with PH and PAWP&gt;18mmHg</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>assessment of DLNO and DLCO</intervention_name>
    <arm_group_label>postcapillary</arm_group_label>
    <arm_group_label>precapillary</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with PH
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing right heart catheterization

          -  patients with clear precapillary PH (PAWP&lt;12mmHg) or clear postcapillary PH
             (PAWP&gt;18mmHg)

          -  signed informed consent

        Exclusion Criteria:

          -  patients unable to perform the DLCO test
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Horst Olschewski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Graz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University Graz, Division of Pulmonology</name>
      <address>
        <city>Graz</city>
        <state>Steiermark</state>
        <zip>8010</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 22, 2016</study_first_submitted>
  <study_first_submitted_qc>May 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2016</study_first_posted>
  <last_update_submitted>March 17, 2020</last_update_submitted>
  <last_update_submitted_qc>March 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

